Nuvation Bio NUVB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $143.05M+127% | $62.9M+135% | $26.75M+86.3% | $14.36M+31.0% | $10.96M+39.2% | ||
| $125.55M+9.1% | $115.11M+4.5% | $110.11M+1.0% | $108.99M-1.7% | $110.88M+11.9% | ||
| $154.48M+1.9% | $151.56M+10.3% | $137.37M+14.9% | $119.6M+23.0% | $97.27M+40.5% | ||
| $295.32M+6.2% | $278.06M+8.3% | $256.65M+7.9% | $237.76M-63.0% | $642.39M+7.0% | ||
| $20.34M+48.6% | $13.68M+92.8% | $7.1M+938% | $684K+73.2% | $395K+15.8% | ||
| —— | —— | $15.49M-28.7% | $21.74M-13.2% | $25.05M+1.5% | ||
| -$145.99M+28.7% | -$204.63M+5.9% | -$217.48M-7.2% | -$202.9M+66.5% | -$606.38M-6.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$145.99M+28.7% | -$204.63M+5.9% | -$217.48M-7.2% | -$202.9M+66.5% | -$606.38M-6.8% | ||
| -102.1%+223pp | -325.3%+488pp | -813.1%+600pp | -1,413.4%+4,121pp | -5,534.2%+1,680pp | ||
| -$148.21M+29.9% | -$211.33M+8.7% | -$231.55M-3.6% | -$223.59M+64.5% | -$630.5M-6.5% | ||
| -103.6%+232pp | -336%+530pp | -865.7%+692pp | -1,557.6%+4,197pp | -5,754.3%+1,764pp | ||
| -$150.18M+29.5% | -$213.06M+8.5% | -$232.97M-3.7% | -$224.64M+64.4% | -$631.43M-6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvation Bio's profit margins?
- Gross margin is 54.3% and operating margin is -105.0%, with a -102.1% net margin.
- Where does Nuvation Bio's income statement data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.